{"id":"W3169669455","doi":"10.1200/jco.2021.39.15_suppl.tps2071","title":"A phase 1/2 study of selinexor in combination with standard of care therapy for newly diagnosed or recurrent glioblastoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Karyopharm Therapeutics","keywords":"Medicine; Temozolomide; Oncology; Internal medicine; Radiation therapy; Phases of clinical research; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005746382,0.00007429937,0.0005960597,0.00004897005,0.00001286954,0.000002807516,0.00008362971,0.0001670981,0.00001447534],"category_scores_gemma":[0.0008794843,0.00004421372,0.0001330161,0.000102752,0.00004681432,0.000004795266,0.00001926149,0.0001642128,6.089356e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002461146,"about_ca_system_score_gemma":0.0007704743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003563852,"about_ca_topic_score_gemma":0.0006841031,"domain_scores_codex":[0.9984077,0.0002418342,0.0009962621,0.0001318171,0.0001431676,0.00007917601],"domain_scores_gemma":[0.9977078,0.0002519204,0.0009163141,0.0001207889,0.0009516554,0.00005147966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2487288,0.01294421,0.01168912,0.00007048552,0.0004647986,0.0001239022,0.001173084,0.0001117168,0.01539085,0.00002172362,0.001364761,0.7079166],"study_design_scores_gemma":[0.1099929,0.7748522,0.01456473,0.00008062328,0.0001597995,0.00005177342,0.005969834,0.00003561352,0.02571272,0.00007916912,0.06837141,0.0001292405],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998203,0.0003872751,0.0004449469,0.0002397971,0.0004296247,0.0002553462,0.00001310067,8.505911e-7,0.00002609405],"genre_scores_gemma":[0.9974118,0.000459521,0.001758009,0.0001095447,0.0002209998,0.000004884694,0.000008888327,0.0000093173,0.00001701528],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.761908,"threshold_uncertainty_score":0.1802983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04485776485031373,"score_gpt":0.4307023348064595,"score_spread":0.3858445699561458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}